Essential oils are natural products, derived from aromatic plants, traditionally used
all over the world for disinfection, as anti-inflammatory, relaxing, and stimulating
substances, and with potential and modern exploitation in clinical medicine. The earliest
recorded mention of the techniques and methods used to produce essential oils is believed
to be that of Ibn al-Baitar (1188–1248). The chemical composition of these essential
oils varies widely depending upon the geographical location, botanical origin, genetics,
bacterial endophytes, and extraction techniques. Essential oils are commonly used
in food and cosmetic industries. They can be used as natural alternatives to synthetic
preparations to prevent and treat infectious diseases. They are used traditionally
to treat other diseases like respiratory tract, digestive system, gynecological, andrological,
endocrine, cardiovascular, nervous system, and skin infections. Many of them have
shown anticancer activities, too.
For this special issue we received seventeen papers, confirming the interest shown
by the scientific community on a great number of old and new issues still open about
essential oil, particularly chemical characterization and standard methods to control
quality; human clinical and experimental pharmacology and toxicology of essential
oils; safety; pharmacological actions and interactions; new biomedical targets of
the biological responses; clinical assays to pharmaceutical products with essential
oils in biotechnology; nanotechnology and nanomedicine. We have selected seven papers,
with the aim of showing some progress made by the pharmaceutical point of view and
the new perspectives of pharmacological research to facilitate their transition into
clinical practice.
In the study “Hepatoprotective effect of pretreatment with Thymus vulgaris essential
oil in experimental model of acetaminophen-induced injury,” R. Grespan et al. investigated
the hepatoprotective effect of Thymus vulgaris essential oil on acetaminophen-induced
hepatic damage in mice. Thymus vulgaris is used popularly such as its antiseptic,
carminative, and antimicrobial effects, and this study is very interesting for new
possible clinical applications. The positive results are confirmed by reduction of
the serum marker enzymes aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and myeloperoxidase (MPO) and by histopathological analysis. Acute liver damage
caused by acetaminophen overdose is a significant clinical problem and could benefit
from new therapeutic strategies.
In the paper entitled “Exploring the anti-Burkholderia cepacia complex activity of
essential oils: a preliminary analysis,” I. Maida et al. have checked the ability
of the essential oils extracted from six different aromatic plants to inhibit the
growth of 18 known species of the Burkholderia cepacia complex (Bcc), an opportunistic
human pathogen that can cause severe infection in immunocompromised patients, especially
those affected by cystic fibrosis (CF) and who are often resistant to multiple antibiotics.
Eugenia caryophyllata, Origanum vulgare, and Thymus vulgaris essential oils were particularly
active versus the Bcc strains, including those exhibiting a high degree or resistance
to ciprofloxacin, active toward both environmental and clinical strains isolated from
CF patients.
N. El Abed et al. in the work “Chemical composition, antioxidant and antimicrobial
activities of Thymus capitata essential oil with its preservative effect against Listeria
monocytogenes inoculated in minced beef meat” evaluated the preservative effect of
Thymus capitata essential oil (TCEO) against Listeria monocytogenes inoculated in
minced beef meat. The antioxidant activity was assessed in vitro by using both the
DPPH and the ABTS assays. The essential oil was evaluated for its antimicrobial activity
using disc agar diffusion and microdilution methods. The results demonstrated that
the minimum inhibition concentration values ranged from 0.32 to 20 mg/mL, and essential
oil evaluated in vivo against Listeria monocytogenes showed clear and strong inhibitory
effect. The application of 0.25 or 1% (v/w) of TCEO to minced beef significantly reduced
the L. monocytogenes population.
In the paper “Essential oils for complementary treatment of surgical patients: state
of the art” S. Stea et al. revised the available literature to determine the effectiveness
of aromatherapy in surgical patients (to treat anxiety and insomnia, pain and nausea,
or to dress wounds). Efficacy studies of lavender or orange and peppermint essential
oils, to treat anxiety and nausea, respectively, have shown positive results. Therefore
there are encouraging data for the treatment of infections, especially for tea tree
oil (TTO). The authors conclude that it is important that the therapeutic use of essential
oils be performed in compliance with clinical safety standards.
In the article “Effect of eugenol on cell surface hydrophobicity, adhesion, and biofilm
of Candida tropicalis and Candida dubliniensis isolated from oral cavity of HIV-infected
patients” S. B. de Paula et al. evaluated the effect of eugenol on the adherence properties
and biofilm formation capacity of Candida dubliniensis and Candida tropicalis isolated
from the oral cavity of HIV-infected patients. Eugenol showed inhibitory activity
against planktonic and sessile cells of Candida spp. Scanning electron microscopy
demonstrated that eugenol drastically reduced the number of sessile cells on denture
material surfaces. The paper corroborates the effectiveness of eugenol against Candida
species other than C. albicans, reinforcing its potential as an antifungal applied
to limit both the growth of planktonic cells and biofilm formation on different surfaces.
In the work “Essential oils loaded in nanosystems: a developing strategy for a successful
therapeutic approach” A. R. Bilia et al. revised the nanoencapsulation of essential
oils in drug delivery systems, for their capability of decreasing volatility, improving
the stability, water solubility, and efficacy of essential oil-based formulations,
by maintenance of therapeutic efficacy. Two categories of nanocarriers can be proposed:
polymeric nanoparticulate formulations, extensively studied with significant improvement
of the essential oil antimicrobial activity, and lipid carriers, including liposomes,
solid lipid nanoparticles, nanostructured lipid particles, and nano/microemulsions.
Lastly, the paper by A. R. Bilia et al. entitled “Essential oil of Artemisia annua
L.: an extraordinary component with numerous antimicrobial properties” describes the
qualitative composition and the antimicrobial activities of essential oil of Artemisia
annua L., a medicinal plant from China, well known and used in the treatment of the
chloroquine-resistant and cerebral malaria. The essential oil of A. annua is rich
in mono- and sesquiterpenes (camphor, germacrene D, artemisia ketone, and 1,8 cineole)
exciting a lot of antibacterial and antifungal activities: against gram-positive bacteria
(Enterococcus, Streptococcus, Staphylococcus, Bacillus, and Listeria spp.), gram-negative
bacteria (Escherichia, Shigella, Salmonella, Haemophilus, Klebsiella, and Pseudomonas
spp.), and mycetes (Candida, Saccharomyces, and Aspergillus spp.). The authors believe
that this review will serve to prepare the most appropriate microbiological studies
also useful for clinical practice.
Fabio Firenzuoli
Vikas Jaitak
Gyorgyi Horvath
Imaël Henri Nestor Bassolé
William N. Setzer
Luigi Gori